MREO vs MSFT: Which Stock is Better?
Side-by-side comparison of Mereo Biopharma Group Plc and Microsoft Corp in 2026
MREO
Mereo Biopharma Group Plc
$0.57
MSFT
Microsoft Corp
$454.50
Key Metrics Comparison
| Metric | MREO | MSFT | Winner |
|---|---|---|---|
| Market Cap | $89.93M | $3.38T | MSFT |
| P/E Ratio | N/A | 36.30 | MSFT |
| EPS (TTM) | $N/A | $13.70 | MSFT |
| Revenue Growth | 0.0% | 14.9% | MSFT |
| Gross Margin | 73.4% | 68.8% | MREO |
Analyze MREO
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is MREO or MSFT a better investment?
Comparing MREO and MSFT: Mereo Biopharma Group Plc has a market cap of $89.93M while Microsoft Corp has $3.38T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between MREO and MSFT?
MREO (Mereo Biopharma Group Plc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: MREO or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: MREO or MSFT?
MSFT has higher revenue growth at 14.9% vs 0.0% for MREO.
Which company is more profitable: MREO or MSFT?
Mereo Biopharma Group Plc (MREO) has higher gross margins at 73.4% compared to 68.8% for MSFT.
Which is the larger company: MREO or MSFT?
Microsoft Corp (MSFT) is larger with a market cap of $3.38T compared to $89.93M for MREO.
Should I buy MREO or MSFT in 2026?
Both MREO and MSFT have investment merit. MREO trades at $0.57 while MSFT trades at $454.50. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between MREO and MSFT stock?
Key differences: Market Cap ($89.93M vs $3.38T), P/E Ratio (N/A vs 36.3x), Revenue Growth (0.0% vs 14.9%), Gross Margin (73.4% vs 68.8%).